You'll See More "Concomitant" Quadruple Therapy for H. pylori
You'll see changes in preferred drug regimens for H. pylori.
Triple therapy with a PPI and two antibiotics (Prevpac, etc) will fall out of favor. It's not as reliable now that clarithromycin resistance exceeds 15% in many parts of North America.
Expect to see a shift based on new guidelines...with more use of QUADRUPLE therapy and treating for 14 days instead of 7 to 10 days.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 200+ CE courses, including the popular CE-in-the-Letter
- Quick reference drug comparison charts
- Access to the entire archive
Already a subscriber? Log in
Volume pricing available. Get a quote